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Kaposi’s sarcoma (KS) is a malignant vascular tumor, caused by the human herpesvirus 8. It is one of the commonest tumors
in human immunodeficiency virus (HIV) patients and not uncommonly the first manifestation of acquired immunodeficiency
syndrome (AIDS). Case. We present a case of an isolated bulbar conjunctival KS on a 43-year-old HIV positive male, with
no other lesions. Excision and cryotherapy were performed, and the patient remains free of lesions to date. Conclusion.
Isolated bulbar conjunctival KP is an unusual site for its initial presentation and must be kept in mind in HIV positive
patients.
1. Introduction
Ocular manifestations of acquired immunodeficiency syn-
drome (AIDS) are varied, affecting almost all structures of
the eye. The posterior segment is mainly affected; however,
less frequently ocular adnexa, anterior segment, orbit, and
neuroophthalmic lesions can also occur. Human immunod-
eficiency virus- (HIV-) associated disease occurs in 50–90%
of patients in the course of their illness [1].
Kaposi’s sarcoma (KS) is the most common lesion of
the anterior segment in these patients [2]. It is an AIDS
defining illness and affects about 30% of the patients with
HIV [2]. It may indicate worsening of the underlying dis-
order appearing in patients with CD4 count <500 cels/𝜇
[1].
KS is a malignant neoplasm of the vascular endothelium
that can affect the eyelids, the lacrimal sac or gland, the
orbit, and bulbar or palpebral conjunctiva. Isolated KS of the
conjunctiva was first reported in 1967 [3]. If it affects the
conjunctiva, it appears as a bright red fleshy to violaceous
nodular mass, commonly seen in the fornix [2, 4].
We report a clinical case of a patient with an isolated
conjunctival KS and its treatment.
2. Case Report
A43-year-oldHIV positivemale since August 2010 presented
with a three-month history (since December 2010) of a
growing mass in the bulbar conjunctiva of the right eye.
The patient had previously undergone right eye cataract
extraction with insertion of intraocular lens in 1992 in
another medical institution.
On ophthalmic examination, the best corrected visual
acuity was 20/25 on his right eye.The biomicroscopy revealed
two reddish nodular lesions localized in the superior and
inferior nasal bulbar conjunctiva, loosely connected to the
underlying tissue (Figure 1). Fundoscopywas normal.The left
eye showed no abnormalities. Screening and confirmatory
tests were positive for HIV with CD4+ lymphocyte cell count
of 154 cells/mm3.
An excisional biopsy and cryotherapy on the conjunctival
edges were done on January 2011. Histologic report of the
biopsy was consistent with the diagnosis of KS with con-
junctival edges free of neoplasm (Figure 2). CD31 and CD34
immunohistochemical stains were positive (Figure 3). CD31
is an endothelial cell marker, CD34 is an important adhesion
molecule required for T cells, and both are markers for
KS.
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Figure 1: Preoperative biomicroscopy.
(a) (b)
Figure 2: Histopathological finding (a) hematoxylin and eosin stain, (b) peroxide acid-Schiff stain.
(a) (b)
Figure 3: Immunohistochemistry (a) CD31, (b) CD34.
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Figure 4: Postoperative biomicroscopy.
The patient initiated standard antiretroviral therapy in
January 2011 and remains in followup in the Infectious
Diseases Department. Two years later the patient remains
with no signs of recurrence (Figure 4).
3. Discussion
Improved survival as a result of antiretroviral therapy has led
to an increase in systemic and ocular complications. KS is
the most common tumor arising in HIV-infected patients.
Ophthalmic presentation often occurs in the context of
systemic KS, and isolated conjunctival lesions are rare [5–7].
KS may affect many structures of the eye. Involvement of
the conjunctiva appears as a flat, reddish lesion, most often
localized in the inferior conjunctiva and fornix. It may be
misdiagnosed with chronic subconjunctival haemorrhage.
The differential diagnosis includes granuloma pyo-
genicum, cavernous haemangioma, foreign-body granuloma,
malignantmelanoma,metastatic tumor, and chronic subcon-
junctival haemorrhage [7].
Dugel et al. [8] have classified adnexal KS clinically into
three stages. In stages 1 and 2, the tumors are patchy and flat
(less than 3mm high), and in stage 3, the tumors are nodular
and elevated (more than 3mm high).
Biopsy with histopathological and immunohistochem-
istry report has an essential role in the diagnosis.
The type of treatment depends on the size and location of
the tumor. KS responds well to treatment by
(1) surgical excision: in extensive, large tumors, loosely
connected with healthy tissue;
(2) radiotherapy: for more extensive lesions;
(3) cryotheraphy: for early flat tumors;
(4) local injection of cytostatics [9, 10].
This case describes an isolated conjunctival Kaposi’s sar-
coma as primary presentation of AIDS, which is an unusual
location for KS [11].
Complete surgical excision with cryotheraphy on con-
junctival edges proved to be effective in our patient, with no
evidence of clinical recurrence.
This case emphasizes the importance of considering KS
as a possible diagnosis in HIV positive patients. Also, KS can
be the first AIDS-defining illness in patients with decreased
immunological response.
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